Ajanta Pharma P/B Ratio
Ajanta Pharma (AJANTPHARM) P/B ratio is 9.71 (High), book value per share ₹1810.80 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Read AJANTPHARM ex-dividend dates for the complete payout history and dividend yield track record.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
AJANTPHARM P/B Ratio — Valuation Insights & Book Value Analysis
Ajanta Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 9.71 (High). For live price, earnings yield and the full fundamental profile, see AJANTPHARM stock price BSE.
- Stock appears overvalued with PB of 9.71, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 504.6% above historical average
- Trading at premium to sector average PB of -0.01
Ajanta Pharma P/B Ratio Historical Trend
AJANTPHARM annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Explore Ajanta Pharma intrinsic price to estimate fundamental worth using multiple valuation models.
AJANTPHARM Historical P/B Ratio — Book Value Per Share & Year-End Price
Ajanta Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 1.97 | ₹1810.8 | ₹3563.60 | ₹4,527 | Moderate |
| 2025 | 1.83 | ₹1516.0 | ₹2768.90 | ₹3,790 | Moderate |
| 2024 | 2.06 | ₹1426.8 | ₹2932.20 | ₹3,567 | Moderate |
| 2023 | 1.54 | ₹1355.2 | ₹2083.65 | ₹3,388 | Moderate |
| 2022 | 0.63 | ₹1920.0 | ₹1211.95 | ₹3,264 | Low |
AJANTPHARM vs Healthcare Peers — P/B Ratio Comparison
Ajanta Pharma P/B 9.71 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |